Immunology: Pimp my antibody
Nature.com (subscription) - London,England,UK
Biogen Idec and Elan relaunched Tysabri last July under a tightly controlled programme so that it can track and respond to any suspected side effects. ...
See all stories on this topic

Elan drops 7pc on higher Q1 loss, Tysabri sales
Irish Independent - Dublin,Ireland
ELAN'S first quarter loss more than doubled and unspectacular sales from the performance of the company's multiple sclerosis treatment Tysabri following its ...
See all stories on this topic

Where Is Elan Going?
Motley Fool - USA
With a highly leveraged balance sheet and a net loss of $93 million this quarter, Elan desperately needs Tysabri sales to pick up. ...
See all stories on this topic

A Touch of Elan: Fool by Numbers
Motley Fool - USA
Revenue grew by a whopping 31%, reflecting strong performance of Tysabri, as around 12500 patients have entered the TOUCH registration program with 9100 ...
See all stories on this topic